Phase I open-label, multiple ascending dose trial of MSB0010718C, an anti-PD-L1 monoclonal antibody, in advanced solid malignancies.
Christopher Ryan Heery
No relevant relationships to disclose
Geraldine Helen O'Sullivan Coyne
No relevant relationships to disclose
Ravi Amrit Madan
No relevant relationships to disclose
Jeffrey Schlom
Honoraria - EMD Serono
Anja von Heydebreck
Employment or Leadership Position - Merck KGaA
Stock Ownership - Merck KGaA
Jean-Marie Cuillerot
Employment or Leadership Position - EMD Serono
Stock Ownership - Bristol-Myers Squibb
Helen Sabzevari
Employment or Leadership Position - EMD Serono
James L. Gulley
No relevant relationships to disclose